Downregulation of Ca2+ and Mg2+ Transport Proteins in the Kidney Explains Tacrolimus (FK506)-Induced Hypercalciuria and Hypomagnesemia

Journal of the American Society of Nephrology

Volumn 15, Issue 3, 2004, Pages 549-557

  Nijenhuis, Tom ^a   Hoenderop, Joost G J ^a   Bindels, René J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALCIUM TRANSPORT PROTEIN; CARRIER PROTEIN; CATION CHANNEL; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; MAGNESIUM TRANSPORT PROTEIN; MESSENGER RNA; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CHANNEL TRPV5; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; GENE EXPRESSION; HYPERCALCIURIA; HYPOMAGNESEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE ABSORPTION; MAGNESIUM CHANNEL TRPM6; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; URINARY EXCRETION;

EID: 1542319027     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000113318.56023.B6     Document Type: Article

References (44)

1. Rodino MA, Shane E: Osteoporosis after organ transplantation. Am J Med 104: 459-469, 1998
2. Reid IR: Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol 137: 209-217, 1997
3. Stempfle HU, Werner C, Siebert U, Assum T, Wehr U, Rambeck WA, Meiser B, Theisen K, Gartner R: The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: A prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 73: 547-552, 2002
4. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM: Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50: 1110-1117, 1996
5. McDiarmid SV, Colonna JO, 2nd, Shaked A, Ament ME, Busuttil RW: A comparison of renal function in cyclosporine- and FK506-treated patients after primary orthotopic liver transplantation. Transplantation 56: 847-853, 1993
6. Reid IR, Ibbertson HK: Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 27: 200-204, 1987
7. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112: 352-364, 1990
8. Friedman PA, Gesek FA: Cellular calcium transport in renal epithelia: Measurement, mechanisms, and regulation. Physiol Rev 75: 429-471, 1995
9. 2+ reabsorption in the distal nephron. Ann Rev Physiol 64: 529-549, 2002
10. Hoenderop JG, Willems PH, Bindels RJ: Toward a comprehensive molecular model of active calcium reabsorption. Am J Physiol Renal Physiol 278: F352-F360, 2000
11. Lote CJ, Thewles A, Wood JA, Zafar T: The hypomagnesaemic action of FK506: Urinary excretion of magnesium and calcium and the role of parathyroid hormone. Clin Sci (Lond) 99: 285-292, 2000
12. de Rouffignac C, Quamme G: Renal magnesium handling and its hormonal control. Physiol Rev 74: 305-322, 1994
13. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA: Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81: 51-84, 2001
14. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC: Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31: 171-174, 2002
15. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M: Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31: 166-170, 2002
16. 2+ absorption. J Biol Chem 279: 19-25, 2004
17. 2+ channel in rabbit kidney and intestine. J Am Soc Nephrol 11: 1171-1178, 2000
18. Hoenderop JG, Muller D, Van Der Kemp AW, Hartog A, Suzuki M, Ishibashi K, Imai M, Sweep F, Willems PH, Van Os CH, Bindels RJ: Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12: 1342-1349, 2001
19. 3-independent stimulatory effect of estrogen on the expression of ECaCl in kidney. J Am Soc Nephrol 13: 2102-2109, 2002
20. 2+ transport proteins in kidney. Kidney Int 64: 555-564, 2003
21. Hofmeister R, Bhargava AS, Gunzel P: Value of enzyme determinations in urine for the diagnosis of nephrotoxicity in rats. Clin Chim Acta 160: 163-167, 1986
22. Zolotnitskaya A, Satlin LM: Developmental expression of ROMK in rat kidney. Am J Physiol 276: F825-F836, 1999
23. 28kDa as a possible mechanism mediating cyclosporine A- and FK506-induced calciuria and tubular mineralization. Biochem Pharmacol 53: 723-731, 1997
24. 3-1α-hydroxylase knockout mice. FASEB J 16: 1398-1406, 2002
25. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815, 1991
26. Fruman DA, Klee CB, Bierer BE, Burakoff SJ: Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 89: 3686-3690, 1992
27. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA: FK506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692-694, 1992
28. 28kDa in rat kidney. Biochem Pharmacol 51: 253-258, 1996
29. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH: A cytosolic binding protein for the immunosuppressant FK506 has peptidylprolyl isomerase activity but is distinct from cyclophilin. Nature 341: 755-757, 1989
30. Harding MW, Galat A, Uehling DE, Schreiber SL: A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758-760, 1989
31. Schreiber SL: Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287, 1991
32. Goel M, Garcia R, Estacion M, Schilling WP: Regulation of Drosophila TRPL channels by immunophilin FKBP59. J Biol Chem 276: 38762-38773, 2001
33. 2+ release channel (ryanodine receptor). J Biol Chem 278: 3786-3792, 2003
34. 3 receptor channels by the FK506-binding protein, FKBP12. Biochem J 361: 401-407, 2002
35. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH: Immunophilin FK506 binding protein associated with inositol 1, 4, 5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A 92: 1784-1788, 1995
36. Runnels LW, Yue L, Clapham DE: TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001
37. 2+-ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001
38. MacDonald P, MacKenzie S, Ramage LE, Seckl JR, Brown RW: Corticosteroid regulation of amiloride-sensitive sodium-channel subunit mRNA expression in mouse kidney. J Endocrinol 165: 25-37, 2000
39. Velazquez H, Bartiss A, Bernstein P, Ellison DH: Adrenal steroids stimulate thiazide-sensitive NaCl transport by rat renal distal tubules. Am J Physiol 270: F211-F219, 1996
40. Chen Z, Vaughn DA, Blakely P, Fanestil DD: Adrenocortical steroids increase renal thiazide diuretic receptor density and response. J Am Soc Nephrol 5: 1361-1368, 1994
41. Loffing J, Lotscher M, Kaissling B, Biber J, Murer H, Seikaly M, Alpern RJ, Levi M, Baum M, Moe OW: Renal Na/H exchanger NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states. J Am Soc Nephrol 9: 1560-1567, 1998
42. + transporter abundances in response to chronic thiazide or loop diuretic treatment in rats. Am J Physiol Renal Physiol 284: F133-F143, 2003
43. --cotransporter abundance: Role of aldosterone. J Am Soc Nephrol 12: 1335-1341, 2001
44. Ellison DH, Velazquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83: 113-126, 1989